| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/30/2006 | CA2580250A1 Loxapine analogs and methods of use thereof |
| 03/30/2006 | CA2579820A1 Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity |
| 03/30/2006 | CA2579623A1 Agent for treating or preventing diabetic neuropathy |
| 03/30/2006 | CA2579406A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors |
| 03/30/2006 | CA2579169A1 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 03/30/2006 | CA2579166A1 Use of il-17f for the treatment and/or prevention of neurologic diseases |
| 03/30/2006 | CA2578953A1 Memantine for the treatment of childhood behavioral disorders |
| 03/30/2006 | CA2575790A1 The use of a modafinil compound for the treatment of problem gambling |
| 03/30/2006 | CA2543757A1 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
| 03/30/2006 | CA2521421A1 C-mycer.tam. induced human neural stem cell lines |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1640369A1 Thiazolimine compound and oxazolimine compound |
| 03/29/2006 | EP1640367A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof |
| 03/29/2006 | EP1640366A1 Heterocyclic methyl sulfone derivative |
| 03/29/2006 | EP1640359A2 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides |
| 03/29/2006 | EP1640017A1 Remedies for diseases with hypermyotonia |
| 03/29/2006 | EP1640007A1 Antiepileptic agent |
| 03/29/2006 | EP1639997A1 Matrix for sustained, invariant and independant release of active compounds |
| 03/29/2006 | EP1639996A1 Matrix for sustained, invariant and independant release of active compounds |
| 03/29/2006 | EP1639139A2 Methods for the diagnosis and prognosis of alzheimer's disease |
| 03/29/2006 | EP1638976A1 Quinoline 3-amino chroman derivatives |
| 03/29/2006 | EP1638969A2 Cgrp receptor antagonists |
| 03/29/2006 | EP1638965A1 Novel 8-aza-bicyclo¬3.2.1|octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/29/2006 | EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 03/29/2006 | EP1638933A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 03/29/2006 | EP1638932A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 03/29/2006 | EP1638931A2 Method of targeting a therapeutic agent |
| 03/29/2006 | EP1638914A2 Compounds useful in the therapy of alzheimer's disease and formulations containing them |
| 03/29/2006 | EP1638605A2 Delivery of therapeutic compounds to the brain and other tissues |
| 03/29/2006 | EP1638589A2 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 03/29/2006 | EP1638569A1 Use of brimonidine for preventing and reducing the severity of stress-associated conditions |
| 03/29/2006 | EP1638565A2 Substituted piperidine compounds and methods of their use |
| 03/29/2006 | EP1638563A1 Treatment for alzheimer' s disease and related conditions |
| 03/29/2006 | EP1638559A1 Use of pyrazolopyridines for the treatment of cognitive deficits |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638536A2 Implantable polymeric device for sustained release of nalmefene |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1482934B1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | EP1414408B1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 03/29/2006 | EP1402270B1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 03/29/2006 | EP1084704B1 Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0932388B1 Dosage form and method for administering drug |
| 03/29/2006 | EP0852495B1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1753694A Remedy for spinal injury containing interleukin-6 antagonist |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753686A Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 03/29/2006 | CN1753675A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 03/29/2006 | CN1753673A Prodrugs of gaba analogs, compositions and uses thereof |
| 03/29/2006 | CN1753672A 4,5-diarylthiazole derivatives as cb-1 ligands |
| 03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/29/2006 | CN1753667A Composition having autonomic nerve modulating activity and method of use thereof |
| 03/29/2006 | CN1753662A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 03/29/2006 | CN1753660A The use of antimuscarinic drugs |
| 03/29/2006 | CN1751691A Small volume intravenous injection of gastrodine and its prepn. method |
| 03/29/2006 | CN1751683A Skeleton type slow-releasing tablets contg. lycopodine-A and its derivatives or its salts and preparing process thereof |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/29/2006 | CN1247591C Indole derivative and its medicine application |
| 03/29/2006 | CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline |
| 03/29/2006 | CN1247588C Adenosine A2A receptor antagonists |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247578C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247571C Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247556C Process for producing dibenzothiazepine derivatives |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247249C Chinese traditional medicine conditioning oral liquid for treating drug withdrawal sydrome |
| 03/29/2006 | CN1247245C Medicine for treating epilepsy |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247203C Helicidum oral disintegation tablet and its preparing method |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019032 Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019025 such as N-(4-{[methyl-(2-propynyl)amino]methyl}phenyl)-2-thiophenecarboximidamine; for inhibiting nitrogen oxide synthases and/or monoamine oxidases |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress |
| 03/28/2006 | US7019016 Therapy of sensorineural hearing loss in a mammal by administering NR2B subunit selective N-methyl-D-aspartate (NMDA) NR2B subtype receptor antagonist |
| 03/28/2006 | US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 03/28/2006 | US7019009 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |